Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Glycopeptide alternative to vancomycin, given as an injection. | Hospital antibiotic for MRSA and C. difficile. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Glycopeptides | Glycopeptides |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | MRSA infections, Bone and joint infections, Endocarditis, Surgical prophylaxis in penicillin allergy | MRSA infections, Sepsis with resistant bacteria, Endocarditis, C. difficile colitis (oral), Meningitis (with other drugs) |
| How it works | Kills certain resistant bacteria by blocking their cell-wall building. | Grabs the building blocks of the bacterial wall so they can't link up. |
| Starts working | Within hours | — |
| Half-life | 70–100 hours | 4–6 hours (longer in kidney disease) |
| Typical adult dose | 400 mg (6 mg/kg) every 12 hours for 3 doses, then 400 mg once a day. | IV: weight-based, adjusted to blood levels. C. difficile: 125 mg by mouth four times a day for 10 days. |
| Forms | IV injection, IM injection | IV infusion, Capsule, Oral solution |
| Common side effects | Pain at the injection site, Rash, Fever, Mild kidney effects | Flushing and itching if infused too fast, Rash, Nausea |
| Serious side effects | Low platelets, Kidney injury, Hearing damage, Severe allergic reaction | Kidney injury, Hearing damage, Low white cells |
| Don't take if | Allergy to teicoplanin; cross-sensitivity with vancomycin can occur | — |
| Alcohol | Usually no problem in moderation. No direct interaction. | — |
| Pregnancy | Use with cautionUsed if no alternative. | Use with cautionUsed when needed; levels monitored. |
| Breastfeeding | Use with cautionPoorly absorbed from the gut; generally acceptable. | — |
| In use since | — | 1958 |
| Brand names | United Kingdom: TargocidIndia: Targocid, Teicoplanin (generic)Australia: Targocid | United States: Vancocin, FirvanqUnited Kingdom: Vancocin |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | — |
| ATC code | J01XA02 | J01XA01 |
Taken together
- ModerateTeicoplanin + Vancomycin: Combined kidney toxicity
Both medicines can damage the kidneys; together the risk is higher.